Testimonials From The Pharmaceutical Out-licensing Course
This course is well structured with good content and a great exercise at the end. By attending, you gain creative ways to structure and value deals in order to increase your opportunities. The course also enhances an individual’s ability to look at the big picture and create the optimal path forward for both companies. Thank you!
BioInteractions & PhoelArjun Luthra, Commercial Director / Managing Director - United Kingdom - December 2020 (live online course)
Very good course! It didn’t only give me a summary of what I needed to know, but also all the examples about what had gone wrong or well in the past, which made it understandable and practical. David has a lot of experience and shares it in a practical way. Recommended!
StabicanIvo Schefman, CEO - The Netherlands - December 2020 (live online course)
High quality course, with lots of hands-on information and an experienced instructor.
InspheroJan Lichtenberg, CEO - Switzerland - December 2020 (live online course)
David was an incredible guide and mentor throughout the 2-day course. Material covered was practical and useful for immediate application. The people, cadence and atmosphere were relaxed and open for all questions and doubts.
Iterative ScopesLavi Erisson, Chief Business Officer - United States - December 2020 (live online course)
I highly valued this course! Good overview, good documentation!
XinnateHelene Hartmann, CEO - Sweden - December 2019 (face-to-face course)
Very useful! The practical experiences of real life scenarios helped bring the process to life.
University of DundeeNigel McLean, Technology Transfer Manager - United Kingdom - December 2019 (face-to-face course)
Very efficient course for Biotech executives. Necessary before negotiation with big pharma biz dev team.
EneapharmKarim Ioualalen, President CEO - France - October 2019 (face-to-face course)
I learned a lot and the content was just right. Also, the exercises helped a lot to put the theory into practice.
Monocl Strategy & CommunicationPaola Jo, Management Consultant - Sweden - October 2019 (face-to-face course)
Excellent course! It’s hands-on and given by a very experienced expert. Highly recommended.
DalCor PharmaceuticalsBruno Pirovino-Zürcher, Director - Switzerland - May 2019 (face-to-face course)
David Scott is a great speaker. He was able to convey the basics of the licensing process in a very simple, clear, and structured manner.
MabylonTiziana Sonati, Director of Operations and Portfolio Manager - Switzerland - May 2019 (face-to-face course)
I can recommend this course to any person from BD and mainly legal and clinical & regulatory, involved in BD deals execution.
GlenmarkSvetlana Bolsheva, BD Director Russia & CIS - Russia - May 2019 (face-to-face course)
Great course. Lots of useful info at the right level delivered.
Modra PharmaceuticalsEric van der Putten, CEO - The Netherlands - November 2018 (face-to-face course)
I attended other courses before, but this one was the most structured and clearest of all. The expert, David Scott, is a wonderful speaker and the material provided is excellent.
PeptomycLaura Soucek, CEO - Spain - November 2018 (face-to-face course)
I would definitely recommend this course for managers who would like to get a solid background on out-licensing, whether you are an expert in business development or an R&D person or a scientific person. This course will provide you with enough knowledge to manage a licensing deal or to understand it when outsourced to third parties.
CinnaGenShayan Sheykholeslami, Market Development Director - Iran - November 2018 (face-to-face course)
Great content, very useful!
PeptomycMarie-Eve Beaulieu, Chief Scientific Officer - Spain - November 2018 (face-to-face course)
Great course, with first an overview of the different kind of deals and the process of out-licensing and then a wonderful action plan, full of tips and useful information!
ENYO PharmaTatiana Dantheny, Head of the CEO Project Office - France - November 2018 (face-to-face course)
The expert was professional, clear, and available to give help and support also during the practical session.
Ospedale San RaffaeleAurora Negro, Contract Management - Italy - April 2018 (face-to-face course)
Thank you for this great course! I highly valued the overview we got.
Vifor PharmaSanjiv Verma, Regulatory Affairs International Manager - Switzerland - April 2018 (face-to-face course)
Well organized and focused on the most relevant aspects related to licensing!
Ospedale San RaffaeleDaniela Rosa Deponti, IP Management - Italy - April 2018 (face-to-face course)
It was a very interesting learning experience which provided a good background and general overview of the pharmaceutical out-licensing process. David Scott presented highly relevant content which he backed up by examples from his personal experiences from the industry, such as pitfalls and success stories. I can warmly recommend the course to life science professionals seeking to obtain a general understanding of pharmaceutical out-licensing.
Monocl Strategy ServicesJonathan Holmén, Senior Associate & Project Leader - Sweden - November 2017 (face-to-face course)
This has been a really useful and informative course! I also highly valued the examples of situations from David’s personal experience.
UCL Business PLCChristina Panaretou, Senior Business Analyst - United Kingdom - May 2017 (face-to-face course)
High quality, well-considered content. Time was well managed to get the most out of the two days. Excellent.
AlfacyteGillian Brown, CEO - United Kingdom - May 2017 (face-to-face course)
Attending this course gives you a good plan on how to approach out-licensing. You can gain a lot in this course by training on examples and learning from the pitfall experiences of David.
AOP Orphan PharmaceuticalsJohannes Pilz, Business Development Manager - Austria - May 2017 (face-to-face course)
Overall a very good experience, highly relevant content and backed up by a very experienced and personable speaker.
Oxford PharmascienceChris Hill, Chief Financial Officer - United Kingdom - October 2016 (face-to-face course)
For those who are interested in extending their basic knowledge of out-licensing, business negotiations, risk assessment and decision making, C.E.L.forpharma’s “The Pharmaceutical Out-licensing Course” is the best option you can find. Experienced lecturer with wide knowledge in the industry and friendly atmosphere will help you to absorb maximum benefits from the course. Especially recommended for junior-middle specialists.
BIOCADDmitry Pasechnik, Head of Overseas Commercial Strategy - Russia - October 2016 (face-to-face course)
For someone who is new to Pharmaceutical Out-licensing, this course is a must and provides an excellent foundation covering all the elements which are important. David Scott is a very experienced and pragmatic global expert in licensing and business development. His anecdotes and real live examples made the theory very clear and easy to follow. I very much enjoyed the two day course and interactions.Michael Frizberg, - Switzerland - October 2016 (face-to-face course)
David’s course sets a solid framework to pharmaceutical licensing. His lectures are backed up by many personal experiences, which makes it all very relevant. It was an all-rounded course, and great enjoyment to participate in!
Alghanim HealthcareNadine Zouk, Business Development & QA Manager - Kuwait - October 2016 (face-to-face course)
This course is top quality thanks to the pharma expert, David Scott, and C.E.L.forpharma’s organisation. The program is complete and easily covered in 2 days.
Legacy HealthcareAngelo Mello, Director Business Development & Licensing - Switzerland - April 2016 (face-to-face course)
This course provided a great overview of the out-licensing process. David was an excellent instructor and prepared us for all possible scenarios.
Cetylite IndustriesAnthony Moreira, Business Development Manager - United States - April 2016 (face-to-face course)
David Scott’s course covers all aspects of pharmaceutical out-licensing, and you can meet like-minded people while on the course. I highly recommend it!
WockhardtPrafulla Kirdant, Business Development & Licensing Executive - United Kingdom - April 2016 (face-to-face course)
David Scott's pharma out-licensing course was a great experience in a warm atmosphere!
Cinfa BiotechDieter Braun, Director Business Development - Germany - April 2015 (face-to-face course)
David clearly is an expert in this field, and as a real expert, he knows how to make things clear and easily understandable. I feel like I have my work programme for the coming months!
Aelis PharmaValerie Scappaticci, President - France - November 2014 (face-to-face course)
The best out-licensing course! A lot of information provided and well structured.
AJA PharmaFaisal Dail, Deputy General Manager - Saudi Arabia - June 2014 (face-to-face course)
This course was recommended to me by the CEO of Poxel and it was indeed a brilliant course! Thanks!
PoxelDaniel Cravo, Medchem & Patent Manager - France - October 2013 (face-to-face course)
I already attended the business development and valuation courses and again, I am very satisfied. The out-licensing course was perfect on all dimensions: expert, course content, organization and audience. I rated this course top level on all parameters - congratulations!
Mitotech PharmaNatalia Perekhvatova, Director - UK - October 2013 (face-to-face course)
Well prepared, perfectly tailored course, valuable for an innovative professional audience and biotech.
TemapharmMichal Szymanowski, Business Development Manager - Poland - March 2013 (face-to-face course)
David provided a very well structured overview of the licensing process. Also the interactions and discussions between the participants made this a very interesting and joyful training.
PROVAXSSven Arnouts, Business Developer - Belgium - March 2013 (face-to-face course)
Very clear presentation. Speakers with many years of experience (like David Scott) are highly valuable to course participants.
Venture ValuationPaul Kochman, Support Biotechgate and independent valuations - Switzerland - October 2012 (face-to-face course)
David Scott has a lot of expertise, being able to deliver it clearly to an audience that is quite differentiated (nationalities, realities, backgrounds).
Merck SeronoSergio Hernandez, Director Business Development - Mexico - October 2012 (face-to-face course)
I would recommend to any BD executive to get this knowledge before (!) starting a serious deal.
AVVAValeriy Tupolev, Head of Business Development - Russia - October 2012 (face-to-face course)
Very thorough breakdown of the out-license procedure, great company, convenient location, and I left feeling very satisfied.
GW PharmaceuticalsJames Brodie, Business Development Scientist - UK - April 2012 (face-to-face course)
David Scott gave a good overview of the entire licensing process. It was great to be able to discuss questions / issues with someone who has so much knowledge in the area and so much experience from previous deals in several areas.
AcceleratorMaria Fors, CEO - Sweden - April 2012 (face-to-face course)
The Pharmaceutical Out-licensing Course is a very interesting course. A definite to do for those who want to gain out-licensing deals.
SandozOlivia Ceulemans, Business Development Manager - Belgium - April 2012 (face-to-face course)
I am fully satisfied as I got the overview of the out-licensing process by attending this course with David Scott.
Pierre FabreOlivia Gulli, Jurist - France - November 2011 (face-to-face course)
David Scott's pharmaceutical out-licensing course is really good. David has a calm presentation style and uses very good examples to illustrate the theory. I would have loved a 3rd day with more case studies.
NycomedAmalia Graf-Czikajlo, Senior International Commercial Project Manager - Switzerland - June 2011 (face-to-face course)
This training was perfect! David Scott shared a huge amount of experience and expertise in these 2 days.
RocheAndrey Chusov, Business Development Manager - Russia - June 2011 (face-to-face course)
Very good basic course, with lots of practical “nuts and bolts” material. David Scott’s presentation style has a good pacing, offers plenty of time for questions and he uses real life examples. Not much to improve on!
GaldermaBill Carson, Head of Integration Office - USA - June 2011 (face-to-face course)
David Scott did a really good job teaching/benchmarking the fundamentals of licensing. The course was intensive and I enjoyed the vivid discussions during the presentations and the coffee breaks. The course gave a perfect opportunity for networking.
ALK-AbelloUlla Seppala, Manager - Denmark - June 2011 (face-to-face course)
C.E.L.forpharma's pharmaceutical out-licensing course provided a thorough overview of all steps in the out-licensing process. It helped me to structure my practical experience and enriched my knowledge with international practices in out-licensing activities. For the newcomers this course with David Scott is a very useful and unique source of theoretical information, real life examples and problem-solving solutions. The exchange of participant experiences during coffee breaks is invaluable too.
NovartisElena Govorova, Business Development Manager - Russia - November 2010 (face-to-face course)
Excellent coverage of the subject matter; all goals given in the program description were fully met! David Scott offers a well structured course at the right level of detail. There are many valuable insights to gain from an experienced licensing professional and great instructor. Discussions with peers were also very useful. In sum, this course can be recommended not only to novices to the licensing field.
Biotest AGHeidrun Geissler-Schuetter, Director International Business Development - Germany - November 2010 (face-to-face course)
After following this course for two days, one has in-depth understanding of the out-licensing process, the tools needed as well as the challenges and rewards that come along in the out-licensing process. David Scott explains, illustrates and brings across profound knowledge and enthusiasm about this subject. If you are involved in out-licensing, do this course!